"Burkitt Lymphoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.
| Descriptor ID |
D002051
|
| MeSH Number(s) |
C02.256.466.313.165 C02.928.313.165 C04.557.386.480.150.165 C15.604.515.569.480.150.165 C20.683.515.761.480.150.165
|
| Concept/Terms |
Burkitt Lymphoma- Burkitt Lymphoma
- Burkitt Leukemia
- Leukemia, Burkitt
- Leukemia, Lymphoblastic, Burkitt-Type
- Burkitt's Lymphoma
- Burkitts Lymphoma
- Lymphoma, Burkitt's
- Burkitt Cell Leukemia
- Cell Leukemia, Burkitt
- Leukemia, Burkitt Cell
- Burkitt's Tumor
- Burkitts Tumor
- Tumor, Burkitt's
- Burkitt Tumor
- Tumor, Burkitt
- Leukemia, Lymphocytic, L3
- Lymphocytic Leukemia, L3
- L3 Lymphocytic Leukemia
- L3 Lymphocytic Leukemias
- Leukemia, L3 Lymphocytic
- Leukemias, L3 Lymphocytic
- Lymphocytic Leukemias, L3
- Burkitt's Leukemia
- Burkitts Leukemia
- Leukemia, Burkitt's
- Lymphoma, Burkitt
|
Below are MeSH descriptors whose meaning is more general than "Burkitt Lymphoma".
Below are MeSH descriptors whose meaning is more specific than "Burkitt Lymphoma".
This graph shows the total number of publications written about "Burkitt Lymphoma" by people in this website by year, and whether "Burkitt Lymphoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 1 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2009 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Burkitt Lymphoma" by people in Profiles.
-
Mattioni J, Portnoy JE, Moore JE, Carlson D, Sataloff RT. Laryngotracheal mucormycosis: Report of a case. Ear Nose Throat J. 2016 Jan; 95(1):29-39.
-
Walter AW, Ennis S, Best H, Vaughn CP, Swensen JJ, Openshaw A, Gripp KW. Constitutional mismatch repair deficiency presenting in childhood as three simultaneous malignancies. Pediatr Blood Cancer. 2013 Nov; 60(11):E135-6.
-
Kassira N, Pedroso FE, Cheung MC, Koniaris LG, Sola JE. Primary gastrointestinal tract lymphoma in the pediatric patient: review of 265 patients from the SEER registry. J Pediatr Surg. 2011 Oct; 46(10):1956-64.
-
Baker PS, Gold KG, Lane KA, Bilyk JR, Katowitz JA. Orbital burkitt lymphoma in immunocompetent patients: a report of 3 cases and a review of the literature. Ophthalmic Plast Reconstr Surg. 2009 Nov-Dec; 25(6):464-8.
-
Sevilla DW, Gong JZ, Goodman BK, Buckley PJ, Rosoff P, Gockerman JP, Lagoo AS. Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocation. Am J Clin Pathol. 2007 Dec; 128(6):981-91.
-
Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, Petrelli NJ, Dunn SP, Krueger LJ. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res. 2007 Oct 15; 67(20):9762-70.
-
Gomez-Curet I, Perkins RS, Bennett R, Feidler KL, Dunn SP, Krueger LJ. c-Myc inhibition negatively impacts lymphoma growth. J Pediatr Surg. 2006 Jan; 41(1):207-11; discussion 207-11.
-
Guedez L, Martinez A, Zhao S, Vivero A, Pittaluga S, Stetler-Stevenson M, Raffeld M, Stetler-Stevenson WG. Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors. Blood. 2005 Feb 15; 105(4):1660-8.
-
D'Souza BN, Edelstein LC, Pegman PM, Smith SM, Loughran ST, Clarke A, Mehl A, Rowe M, Gélinas C, Walls D. Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor. J Virol. 2004 Feb; 78(4):1800-16.
-
Gong JZ, Stenzel TT, Bennett ER, Lagoo AS, Dunphy CH, Moore JO, Rizzieri DA, Tepperberg JH, Papenhausen P, Buckley PJ. Burkitt lymphoma arising in organ transplant recipients: a clinicopathologic study of five cases. Am J Surg Pathol. 2003 Jun; 27(6):818-27.